340B Dispute Resolution Process Finalized
What’s happening: The Health Resources and Services Administration (HRSA) finalized requirements and procedures for the 340B Drug Discount Program’s administrative dispute resolution (ADR) process.
What else to know: The regulation is effective June 18.
Hospital Leaders Discuss Financial Challenges with Legislators on Capitol Hill
What’s happening: Last week, California hospital and health system leaders convened in Washington, D.C. for the American Hospital Association (AHA) Annual Membership Meeting.
What else to know: Hospital and health system leaders participated in meetings on Capitol Hill with the California congressional delegation to advance CHA’s position on key advocacy priorities.
CHA Comments on Draft 340B Legislation
What’s happening: CHA submitted feedback on draft legislation related to the 340B Drug Pricing Program, which allows rural and safety-net hospitals to buy outpatient drugs at discounted prices.
What else to know: The bipartisan SUSTAIN 340B Act considers significant changes to the 340B program.
Certain 340B Hospitals to Receive Lump-Sum Settlement
What’s happening: A final rule from the Centers for Medicare & Medicaid Services (CMS) contains a remedy for the agency’s 340B-acquired drug payment policy that was in effect from 2018 to 2022.
What else to know: Eligible hospitals will receive a lump-sum settlement for claims, including beneficiary cost sharing, as a result of CMS’ invalidated policy that reduced payments for separately payable outpatient drugs acquired under the 340B program.
Hospitals Have 90 Days to Comply with Off-Site Clinic Requirements
What’s happening: Guidance from the Health Resources and Services Administration (HRSA) affirms it rescinded a COVID-19 public health emergency era waiver related to the 340B Drug Discount Program and off-site clinics.